Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis

Critical Care

Volumn 10, Issue 4, 2006, Pages

  Garnacho Montero, Jose ^a   Aldabo Pallas, Teresa ^a   Garnacho Montero, Carmen ^b   Cayuela, Aurelio ^a   Jiménez, Rocio ^a   Barroso, Sonia ^a   Ortiz Leyba, Carlos ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; INTERLEUKIN 10; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT;

ADULT; AGED; APACHE; ARTICLE; BLOOD CULTURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; HOSPITAL INFECTION; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RISK FACTOR; SEPSIS; THERAPY DELAY; COMPARATIVE STUDY; DRUG ADMINISTRATION; GENETICS; MIDDLE AGED; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; HOSPITAL MORTALITY; HUMANS; INTERLEUKIN-10; LYMPHOTOXIN-ALPHA; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; SEPSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249901630     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc4995     Document Type: Article

References (42)

1. Angus DC Linde-Zwirble WT Lidicker L Clermont G Carcillo J Pinsky MR Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care Crit Care Med 2001 29 1303-1310 10.1097/00003246-200107000-00002 11445675
2. Annane D Aegerter P Jars-Guincestre MC Guidet B CUB-Rea Network Current epidemiology of septic shock Am J Respir Crit Care Med 2003 168 165-172 10.1164/rccm.2201087 12851245
3. Garnacho-Montero J Garcia-Garmendia JL Barrero-Almodovar A Jimenez-Jimenez FJ Perez-Paredes C Ortiz-Leyba C Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis Crit Care Med 2003 31 2742-2751 10.1097/ 01.CCM.0000098031.24329.10 14668610
4. Valles J Rello J Ochagavia A Garnacho J Alcala MA Community-acquired bloodstream infection in critically ill adult patients: Impact of shock and inappropriate antibiotic therapy on survival Chest 2003 123 1615-1624 10.1378/chest.123.5.1615 12740282
5. Yu DT Black E Sands KE Schwartz JS Hibberd PL Graman PS Lanken PN Kahn KL Snydman DR Parsonnet J Severe sepsis: Variation in resource and therapeutic modality use among academic centers Crit Care 2003 7 R24-R34 270675 12793887 10.1186/cc2171
6. Wax RS Angus DC The molecular genetics of sepsis: Clinical epidemiology considerations 2000 Yearbook of Intensive Care and Emergency Medicine Springer: Berlin Vincent JL 2000 3-17
7. Tabrizi AR Zehnbauer BA Freeman BD Buchman TG Genetic markers in sepsis J Am Coll Surg 2001 192 106-117 10.1016/S1072-7515(00)00748-1 11192910
8. American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee Definition for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis Chest 1992 101 1644-1655 1303622
9. Van Dissel JT Van Langevelde P Westendorp RGJ Kwappenberg K Frölich M Anti-inflamatory cytokine profile and mortality in febrile patients Lancet 1998 351 950-953 9734942
10. Mira JP Cariou A Grall P Delclaux C Losser MR Heshmati F Cheval C Monchi M Teboul JL Riche F Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality JAMA 1999 281 1919-1926 10.1001/jama.281.20.1919 10349896
11. Stuber F Udalova IA Book M Drutskaya LN Kuprash DV Turetskaya RL Schade FU Nedospasov SA -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of human promoter J Inflamm 1996 46(1) 42-50
12. Turner DM Williams DM Sankaran D Lazarus M Sinnott PJ Hutchinson IV An investigation of polumorphism in the interleukin-10 gene promoter Eur J Immunogenet 1997 24 1-8 9043871
13. Annane D Sebille V Charpentier C Bollaert PE Francois B Korach JM Capellier G Cohen Y Azoulay E Troche G Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 2002 288 862-871 10.1001/jama.288.7.862 12186604
14. van den Berghe G Wouters P Weekers F Verwaest C Bruyninckx F Schetz M Vlasselaers D Ferdinande P Lauwers P Bouillon R Intensive insulin therapy in critically ill patients N Engl J Med 2001 345 1359-1367 10.1056/NEJMoa011300 11794168
15. The Acute Respiratory Distress Network Ventilation with lower tidal volumes as compared with traditional volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med 2000 342 1301-1308 10.1056/NEJM200005043421801 10793162
16. Knaus WA Draper EA Wagner DP Zimmerman JE APACHE II, a severity of disease classification system Crit Care Med 1985 13 818-829 3928249
17. Pittet D Thiévent B Wenzel RP Li N Gurman G Suter P Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients Intensive Care Med 1993 19 265-272 10.1007/BF01690546 8408935
18. Vincent JL Moreno R Takala J Willatts S De Mendonca A Bruining H Reinhart CK Suter PM Thijs LG The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure Intensive Care Med 1996 22 707-710 8844239
19. Ferreira FL Bota DP Bross A Mélot C Vincent JL Serial evaluation of the SOFA score to predict outcome in critically ill patients JAMA 2001 286 1754-1758 10.1001/jama.286.14.1754 11594901
20. Garnacho-Montero J Madrazo-Osuna J Garcia-Garmendia JL Ortiz-Leyba C Jimenez-Jimenez FJ Barrero-Almodovar A Garnacho-Montero MC Moyano-Del-Estad MR Critical illness polyneuropathy: Risk factors and clinical consequences. A cohort study in septic patients Intensive Care Med 2001 27 1288-1296 10.1007/s001340101009 11511941
21. Hosmer DW Lemeshow SA Applied Logistic Regression New York: John Wiley 1989
22. Houch PM Bratzler DW Nsa W Na A Barlett JG Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia Arch Intern Med 2004 164 637-644 10.1001/ archinte.164.6.637 15037492
23. Aronin SI Peduzzi P Quagliarello VJ Community-acquired bacterial meningitis: Risk stratification for adverse clinical outcome and effect of antibiotic timing Ann Intern Med 1998 129 862-869 9867727
24. Alberti C Brun-Buisson C Burchardi H Martin C Goodman S Artigas A Sicignano A Palazzo M Moreno R Boulme R Epidemiology of sepsis and infection in ICU patients from an international multicentre cohot study Intensive Care Med 2002 28 108-121 10.1007/s00134-001-1143-z 11907653
25. Legras A Malvy D Quinioux AI Villers D Bouachour G Robert R Thomas R Nosocomial infections: Prospective survey of incidence in five French intensive care units Intensive Care Med 1998 24 1040-1046 10.1007/ s001340050713 9840237
26. Rangel-Frausto M Pittet D Costigan M Hwang T Davis CS Wenzel RP The natural history of systemic inflammatory response syndrome (SIRS) JAMA 1995 273 117-123 10.1001/jama.273.2.117 7799491
27. Alberti C Brun-Buisson C Chevret S Antonelli M Goodman SV Martin C Moreno R Ochagavia AR Palazzo M Werdan K Systemic inflammatory response and progression to severe sepsis in critically ill infected patients Am J Resp Crit Care Med 2005 171 461-468 10.1164/rccm.200403-324OC 15531752
28. Tang GJ Huang SL Yien HW Chen WS Chi CW Wu CW Lui WY Chiu JH Lee TY Tumor necrosis factor gene polymorphism and septic shock in surgical infection Crit Care Med 2000 28 2733-2736 10.1097/ 00003246-200008000-00008 10966243
29. Stuber F Petersen M Bokelmann F Schade U A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis Crit Care Med 1996 24 381-384 10.1097/00003246-199603000-00004 8625623
30. Schroeder S Reck M Hoeft A Stuber S Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis Crit Care Med 1999 27 1265-1270 10.1097/ 00003246-199907000-00006 10446818
31. Rauchschwalbe SK Maseizik T Mittelkotter U Schluter B Patzig C Thiede A Reith HB Effect of the LT-alpha (+250 G/A) polymorphism on markers of inflammation and clinical outcome in critically ill patients J Trauma 2004 56 815-822 15187748
32. Gordon AC Lagan AL Aganna E Cheung L Peters CJ McDermott MF Millo JL Welsh KI Holloway P Hitman GA TNF and TNFR polymorphisms in severe sepsis and septic shock: A prospective multicentre study Genes Immunity 2004 5 631-640 10.1038/sj.gene.6364136 15526005
33. Heesen M Kunz D Bachmann-Mannenga B Merk HF Bloemeke B Linkage disequilibrium between tumor necrosis factor (TNF)-α-308 G/A promoter and TNF β Ncol polymorphisms: Association with TNF-α response of granulocytes to endotoxin stimulation Crit Care Med 2003 31 211-214 10.1097/00003246-200301000-00032 12545017
34. Waterer GW Quasney MW Cantor RM Wunderink RG Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations Am J Resp Crit Care Med 2001 163 1599-1604 11401880
35. Gallagher PM Lowe G Fitzgerald T Bella A Greene CM McElvaney NG O'Neill SJ Association of Il-10 polymorphism with severity of illness in community acquired pneumonia Thorax 2003 58 154-156 10.1136/ thorax.58.2.154 12554901
36. Schaff BM Boehmke F Esnaashari H Seitzer U Kothe H Maass M Zabel P Dalhoff K Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism Am J Resp Crit Care Med 2003 168 476-480 10.1164/rccm.200210-1164OC 12746253
37. Bayley JP Ottenhoff THM Verweij CL Is there a future for TNF promoter polymnorphism Genes Immunity 2004 5 315-329 10.1038/sj.gene.6364055 14973548
38. Rivers E Nguyen B Havstad S Ressler J Muzzin A Knoblich B Peterson E Tomlanovich M Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 2001 345 1368-1377 10.1056/NEJMoa010307 11794169
39. Carlet J Prescribing indications based on successful clinical trials in sepsis: A difficult exercise Crit Care Med 2006 34 525-529 10.1097/ 01.CCM.0000198329.85851.8E 16424736
40. Sutherland AM Walley KR Manocha S Russell JA The association of interleukin 6 haplotype with mortality in critically ill adults Arch Intern Med 2005 165 75-82 10.1001/archinte.165.1.75 15642878
41. Colhoun HM Mckeigue PM Smith GD Problems of reporting genetic associations with complex outcomes Lancet 2003 361 865-872 10.1016/ S0140-6736(03)12715-8 12642066
42. Polderman KH, Girbes ARJ: Drug Intervention trials in sepsis: divergent results. Lancet 2004, 363:1721-1723.